Abstract:BACKGROUND Experimental approaches to identify drug-target interactions (DTIs) among a large number of chemical compounds and proteins are still costly and time-consuming. As an assistant, computational approaches are able to rapidly infer potential drug or target candidates for diverse screenings on a large scale. The most difficult scenario (S4) of screenings tries to explore the pairwise interacting candidates between newly designed chemical compounds (new potential drugs) and proteins (new target candidates). Few of current computational approaches can be applied to the inference of potential DTIs in S4 because the new potential drugs have no known target and the new target candidates have no existing drug at all. In addition, due to the essential issues among DTI, such as missing DTIs and the imbalance between few approved DTIs and many unknown drug-target pairs, existing metrics of DTI inference may not reflect the performance of inferring approaches fairly. METHODS To address these issues, this paper develops three instance neighborhood-based models: individualto- individual (I2I), individual-to-group (I2G) and nearest-neighbor-zone (NNZ). In I2I, if a new drug tends to interact with individual targets similar to a new target of interest, it likely interacts with the new target. In I2G, the new drug possibly interacts with the new target if it tends to interact with a target group, in which member targets are similar to each other and one or more of them are similar to the new target. In NNZ, the pair of the new drug and the new target is a potential DTI if it is similar to known existing DTIs. This paper also designs a topological dense index to guide the selection of the appropriate models when given different datasets. Moreover, an additional metric Coverage is introduced to enhance the assessment of DTI inference. RESULTS Performed on four benchmark datasets, our models demonstrate that the instance neighborhood can improve the DTI inference significantly. Under the guidance of our topological dense index, the best models for the datasets are chosen and achieve inspiring performances, including ~85%, ~81%, ~86% and ~81% in terms of AUC and ~29%, ~32%, ~32% and ~33% in terms of AUPR respectively. The superiority of our models is demonstrated by both the comparison with two state-of-the-art approaches and the novel DTI inference. CONCLUSION By leveraging the instance neighborhood, our models are able to infer DTIs in the most difficult scenario S4. Moreover, our topological dense index can guide the appropriate models when given different datasets.

The Computational Models of Drug-target Interaction Prediction

Identification of Drug-Target Interactions Via Multiple Information Integration.

Revealing Drug-Target Interactions with Computational Models and Algorithms

Predicting Drug-Target Interactions Between New Drugs and New Targets via Pairwise K-nearest Neighbor and Automatic Similarity Selection.

Drug-target Interaction Prediction: Databases, Web Servers and Computational Models.

Network-Based Methods for Prediction of Drug-Target Interactions

A Computational Approach For Predicting Drug-Target Interactions From Protein Sequence And Drug Substructure Fingerprint Information

Computational Prediction of DrugTarget Interactions Using Chemical, Biological, and Network Features

Predicting Drug-Target Interactions Via Within-Score and Between-Score

Computational prediction of drug-target interactions using chemogenomic approaches: an empirical survey.

Improved Prediction Of Drug-Target Interactions Based On Ensemble Learning With Fuzzy Local Ternary Pattern

Computational Prediction of DrugTarget Interactions Using Chemical, Biological, and Network Features

Predicting Existing Targets for New Drugs Base on Strategies for Missing Interactions

Drug-Target Interaction Prediction Based On Drug Fingerprint Information And Protein Sequence

An Efficient Computational Method to Predict Drug-Target Interactions Utilizing Structural Perturbation Method

An Ensemble Learning-Based Method for Inferring Drug-Target Interactions Combining Protein Sequences and Drug Fingerprints

Research progress on Drug-Target Interactions in the last five years

Predicting Drug-Target Interaction for New Drugs Using Enhanced Similarity Measures and Super-Target Clustering.

Inferring Interactions Between Novel Drugs and Novel Targets Via Instance-Neighborhood-Based Models.

In silico prediction of drug-target interaction networks based on drug chemical structure and protein sequences

A Systematic Prediction of Drug-Target Interactions Using Molecular Fingerprints and Protein Sequences